In the BioHarmony Drug Report Database
Capreomycin
Capastat Sulfate (capreomycin) is a protein pharmaceutical. Capreomycin was first approved as Capastat Sulfate on 1982-01-01. It is used to treat mycobacterium infections and tuberculosis in the USA.
Trade Name
|
Capastat Sulfate |
|---|---|
Common Name
|
capreomycin |
ChEMBL ID
|
CHEMBL2221250 |
Indication
|
mycobacterium infections, tuberculosis |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)